| Literature DB >> 33080217 |
Violeta Heras1, Juan Manuel Castellano2, Daniela Fernandois3, Inmaculada Velasco1, Elvira Rodríguez-Vazquez1, Juan Roa4, Maria Jesus Vazquez4, Francisco Ruiz-Pino4, Matias Rubio3, Rafael Pineda1, Encarnacion Torres1, Maria Soledad Avendaño1, Alfonso Paredes3, Leonor Pinilla4, Denise Belsham5, Carlos Diéguez6, Francisco Gaytán4, Nuria Casals7, Miguel López6, Manuel Tena-Sempere8.
Abstract
Childhood obesity, especially in girls, is frequently bound to earlier puberty, which is linked to higher disease burden later in life. The mechanisms underlying this association remain elusive. Here we show that brain ceramides participate in the control of female puberty and contribute to its alteration in early-onset obesity in rats. Postnatal overweight caused earlier puberty and increased hypothalamic ceramide content, while pharmacological activation of ceramide synthesis mimicked the pubertal advancement caused by obesity, specifically in females. Conversely, central blockade of de novo ceramide synthesis delayed puberty and prevented the effects of the puberty-activating signal, kisspeptin. This phenomenon seemingly involves a circuit encompassing the paraventricular nucleus (PVN) and ovarian sympathetic innervation. Early-onset obesity enhanced PVN expression of SPTLC1, a key enzyme for ceramide synthesis, and advanced the maturation of the ovarian noradrenergic system. In turn, obesity-induced pubertal precocity was reversed by virogenetic suppression of SPTLC1 in the PVN. Our data unveil a pathway, linking kisspeptin, PVN ceramides, and sympathetic ovarian innervation, as key for obesity-induced pubertal precocity.Entities:
Keywords: PVN; ceramides; childhood obesity; kisspeptin; ovary; puberty; sympathetic tone
Year: 2020 PMID: 33080217 DOI: 10.1016/j.cmet.2020.10.001
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287